Caricamento...
Cancer immunotherapy: exploiting neoepitopes
The efficacy of cancer vaccines has long been hampered by insufficient definition of tumor-specific antigens. A recent study by Kreiter et al. published in Nature has provided a blueprint for a patient-tailored approach to develop individualized RNA vaccines.
Salvato in:
| Pubblicato in: | Cell Res |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4528051/ https://ncbi.nlm.nih.gov/pubmed/26032267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cr.2015.66 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|